To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
BGV wraps up fourth fund
BioGeneration Ventures, an early-stage venture firm focused on European biopharma, has closed its fourth fund at $119 million.
